Experiment: 2KTU

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.8 mM [U-99% 15N] C_ERF1_HUMAN-4, 50 mM potassium chloride-5, 10 mM potassium phosphate-6	90% H2O/10% D2O	0.08	7.0	ambient	298
2	2D 1H-13C HSQC	1 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-10, 50 mM potassium chloride-11, 10 mM potassium phosphate-12	100% D2O	0.08	7.0	ambient	298
3	3D HNCA	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
4	3D HNCACB	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
5	3D HN(CO)CA	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
6	3D CBCA(CO)NH	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
7	3D HBHA(CO)NH	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
8	3D HNCO	0.8 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-7, 50 mM potassium chloride-8, 10 mM potassium phosphate-9	90% H2O/10% D2O	0.08	7.0	ambient	298
9	3D HNHA	0.8 mM [U-99% 15N] C_ERF1_HUMAN-4, 50 mM potassium chloride-5, 10 mM potassium phosphate-6	90% H2O/10% D2O	0.08	7.0	ambient	298
10	3D 1H-15N NOESY	0.8 mM [U-99% 15N] C_ERF1_HUMAN-4, 50 mM potassium chloride-5, 10 mM potassium phosphate-6	90% H2O/10% D2O	0.08	7.0	ambient	298
11	3D 1H-13C NOESY	1 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-10, 50 mM potassium chloride-11, 10 mM potassium phosphate-12	100% D2O	0.08	7.0	ambient	298
12	3D HCCH-TOCSY	1 mM [U-99% 13C; U-99% 15N] C_ERF1_HUMAN-10, 50 mM potassium chloride-11, 10 mM potassium phosphate-12	100% D2O	0.08	7.0	ambient	298
13	2D DQF-COSY	1 mM C_ERF1_HUMAN-1, 50 mM potassium chloride-2, 10 mM potassium phosphate-3	90% H2O/10% D2O	0.08	7.0	ambient	298
14	2D 1H-15N HSQC	0.8 mM [U-99% 15N] C_ERF1_HUMAN-13, 50 mM potassium chloride-14, 10 mM potassium phosphate-15, 5 % C12E5/hexanol-16	90% H2O/10% D2O	0.08	7.0	ambient	311

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Varian	INOVA	700
3	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		VNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	100
Conformers Submitted Total Number	24
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	VNMR		Varian
2	chemical shift assignment	Sparky		Goddard
3	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
4	data analysis	TALOS		Cornilescu, Delaglio and Bax
5	data analysis	Anglesearch	2.10	Polshakov VI & Feeney J.
6	structure solution	CNS 2.1		Linge, O'Donoghue and Nilges
7	refinement	ARIA		BRUNGER, ADAMS, CLORE, DELANO, GROS, GROSSE-KUNSTLEVE, JIANG, KUSZEWSKI, NILGES, PANNU, READ, RICE, SIMONSON, WARREN
8	chemical shift assignment	ARIA		Linge, O'Donoghue and Nilges
9	structure solution	CNSSOLVE		Brunger, Adams, Clore, Gros, Nilges and Read
10	collection	TopSpin		Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.